Spinocerebellar Ataxia Type 7 Sca7 clinical trials

Explore recruiting spinocerebellar ataxia type 7 sca7 clinical trials.

Recruiting spinocerebellar ataxia type 7 sca7 studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Spinocerebellar Ataxia Type 7 Sca7 trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Riluzole (Glentek) in patients with SpinoCerebellar Ataxia type 7: a randomized, doubleblind, placebo-controlled pilot trial with a lead in phase

Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Spinocerebellar Ataxia Type 7 Sca7 trials by city

Spinocerebellar Ataxia Type 7 Sca7 in Toronto Spinocerebellar Ataxia Type 7 Sca7 in Vancouver Spinocerebellar Ataxia Type 7 Sca7 in Montreal Spinocerebellar Ataxia Type 7 Sca7 in Calgary Spinocerebellar Ataxia Type 7 Sca7 in Edmonton Spinocerebellar Ataxia Type 7 Sca7 in Ottawa Spinocerebellar Ataxia Type 7 Sca7 in Winnipeg Spinocerebellar Ataxia Type 7 Sca7 in Quebec City Spinocerebellar Ataxia Type 7 Sca7 in Hamilton Spinocerebellar Ataxia Type 7 Sca7 in Kitchener Spinocerebellar Ataxia Type 7 Sca7 in London Spinocerebellar Ataxia Type 7 Sca7 in Halifax Spinocerebellar Ataxia Type 7 Sca7 in New York Spinocerebellar Ataxia Type 7 Sca7 in Los Angeles Spinocerebellar Ataxia Type 7 Sca7 in Chicago Spinocerebellar Ataxia Type 7 Sca7 in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease